Sequenom

Sequenom (NASDAQ: SQNM) is an American company based in California, that develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT and liquid biopsy for cancer testing. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21 PLUS, a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, RetnaGene AMD a genetic test for the risk of progression for age-related macular degeneration, Heredi-T Cystic Fibrosis Screening Test, and the SensiGene Fetal RHD Genotyping Test.